183 related articles for article (PubMed ID: 23729275)
1. A let-7 binding site polymorphism rs712 in the KRAS 3' UTR is associated with an increased risk of gastric cancer.
Li ZH; Pan XM; Han BW; Guo XM; Zhang Z; Jia J; Gao LB
Tumour Biol; 2013 Oct; 34(5):3159-63. PubMed ID: 23729275
[TBL] [Abstract][Full Text] [Related]
2. Association of a let-7 KRAS rs712 polymorphism with the risk of breast cancer.
Huang X; Yang Y; Guo Y; Cao ZL; Cui ZW; Hu TC; Gao LB
Genet Mol Res; 2015 Dec; 14(4):16913-20. PubMed ID: 26681038
[TBL] [Abstract][Full Text] [Related]
3. Lack of association between let-7 binding site polymorphism rs712 and risk of nasopharyngeal carcinoma.
Pan XM; Jia J; Guo XM; Li ZH; Zhang Z; Qin HJ; Xu GH; Gao LB
Fam Cancer; 2014 Mar; 13(1):93-7. PubMed ID: 23996697
[TBL] [Abstract][Full Text] [Related]
4. A let-7 KRAS rs712 polymorphism increases colorectal cancer risk.
Pan XM; Sun RF; Li ZH; Guo XM; Zhang Z; Qin HJ; Xu GH; Gao LB
Tumour Biol; 2014 Jan; 35(1):831-5. PubMed ID: 23975373
[TBL] [Abstract][Full Text] [Related]
5. A variant in 3'-untranslated region of KRAS compromises its interaction with hsa-let-7g and contributes to the development of lung cancer in patients with COPD.
Hu H; Zhang L; Teng G; Wu Y; Chen Y
Int J Chron Obstruct Pulmon Dis; 2015; 10():1641-9. PubMed ID: 26316738
[TBL] [Abstract][Full Text] [Related]
6. Association between a functional polymorphism rs712 within let-7-binding site and risk of papillary thyroid cancer.
Jin H; Liang Y; Wang X; Zhu J; Sun R; Chen P; Nie X; Gao L; Zhang L
Med Oncol; 2014 Oct; 31(10):221. PubMed ID: 25201577
[TBL] [Abstract][Full Text] [Related]
7. Association of rs712 polymorphism in Kras gene 3'-luntranslated region and cancer risk: a meta-analysis.
Zhao WH; Qu XF; Xing ZG; Zhao LQ; Qin L; Lv C
J BUON; 2015; 20(1):309-16. PubMed ID: 25778332
[TBL] [Abstract][Full Text] [Related]
8. A single nuclear polymorphism in let-7g binding site affects the doubling time of thyroid nodule by regulating KRAS-induced cell proliferation.
Liu A; Zhang W; Zhao T; Xiao M; Mei Q; Zhu H
J Cell Physiol; 2019 Dec; 234(12):23437-23447. PubMed ID: 31152438
[TBL] [Abstract][Full Text] [Related]
9. A Functional Polymorphism in the Promoter of MiR-143/145 Is Associated With the Risk of Cervical Squamous Cell Carcinoma in Chinese Women: A Case-Control Study.
Liang Y; Sun R; Li L; Yuan F; Liang W; Wang L; Nie X; Chen P; Zhang L; Gao L
Medicine (Baltimore); 2015 Aug; 94(31):e1289. PubMed ID: 26252302
[TBL] [Abstract][Full Text] [Related]
10. A let-7 microRNA-binding site polymorphism in the KRAS 3' UTR is associated with reduced survival in oral cancers.
Christensen BC; Moyer BJ; Avissar M; Ouellet LG; Plaza SL; McClean MD; Marsit CJ; Kelsey KT
Carcinogenesis; 2009 Jun; 30(6):1003-7. PubMed ID: 19380522
[TBL] [Abstract][Full Text] [Related]
11. An let-7 KRAS rs712 polymorphism increases hepatocellular carcinoma risk.
Xiong D; Song YP; Xiong W; Liang YD
Genet Mol Res; 2015 Oct; 14(4):14050-5. PubMed ID: 26535719
[TBL] [Abstract][Full Text] [Related]
12. Extensive sequence variation in the 3' untranslated region of the KRAS gene in lung and ovarian cancer cases.
Kim M; Chen X; Chin LJ; Paranjape T; Speed WC; Kidd KK; Zhao H; Weidhaas JB; Slack FJ
Cell Cycle; 2014; 13(6):1030-40. PubMed ID: 24552817
[TBL] [Abstract][Full Text] [Related]
13. Significant association between Let-7-KRAS rs712 G > T polymorphism and cancer risk in the Chinese population: a meta-analysis.
Du XY; Hu YY; Xie C; Deng CY; Liu CY; Luo ZG; Niu YM; Shen M
Oncotarget; 2017 Feb; 8(8):13863-13871. PubMed ID: 28099923
[TBL] [Abstract][Full Text] [Related]
14. Association study of the let-7 miRNA-complementary site variant in the 3' untranslated region of the KRAS gene in stage III colon cancer (NCCTG N0147 Clinical Trial).
Sha D; Lee AM; Shi Q; Alberts SR; Sargent DJ; Sinicrope FA; Diasio RB
Clin Cancer Res; 2014 Jun; 20(12):3319-27. PubMed ID: 24727325
[TBL] [Abstract][Full Text] [Related]
15. A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk.
Chin LJ; Ratner E; Leng S; Zhai R; Nallur S; Babar I; Muller RU; Straka E; Su L; Burki EA; Crowell RE; Patel R; Kulkarni T; Homer R; Zelterman D; Kidd KK; Zhu Y; Christiani DC; Belinsky SA; Slack FJ; Weidhaas JB
Cancer Res; 2008 Oct; 68(20):8535-40. PubMed ID: 18922928
[TBL] [Abstract][Full Text] [Related]
16. Effects of KRAS mutation and polymorphism on the risk and prognosis of oral squamous cell carcinoma.
Wang WY; Chien YC; Wong YK; Lin YL; Lin JC
Head Neck; 2012 May; 34(5):663-6. PubMed ID: 21688344
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of rs712 polymorphism in a let-7 microRNA-binding of KRAS gene in breast cancer of a Mexican population.
Patricia Gallegos-Arreola M; Briseño Zuno CJ; Eduardo Figuera L; Zúñiga González GM; Perales Mederos CI; Puebla Pérez AM; Rosales Reynoso MA
J BUON; 2020; 25(1):176-181. PubMed ID: 32277629
[TBL] [Abstract][Full Text] [Related]
18. A Functional Variant at the miR-214 Binding Site in the Methylenetetrahydrofolatereductase Gene Alters Susceptibility to Gastric Cancer in a Chinese Han Population.
Chen Q; Qin R; Fang Y; Li H; Liu Y
Cell Physiol Biochem; 2015; 36(2):622-30. PubMed ID: 25998065
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-binding site polymorphisms in genes involved in colorectal cancer etiopathogenesis and their impact on disease prognosis.
Schneiderova M; Naccarati A; Pardini B; Rosa F; Gaetano CD; Jiraskova K; Opattova A; Levy M; Veskrna K; Veskrnova V; Buchler T; Landi S; Vodicka P; Vymetalkova V
Mutagenesis; 2017 Oct; 32(5):533-542. PubMed ID: 29048575
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of the variant allele rs61764370 T>G in the 3'UTR of KRAS among Dutch BRCA1, BRCA2 and non-BRCA1/BRCA2 breast cancer families.
Hollestelle A; Pelletier C; Hooning M; Crepin E; Schutte M; Look M; Collee JM; Nieuwlaat A; Dorssers LC; Seynaeve C; Aulchenko YS; Martens JW; van den Ouweland AM; Weidhaas JB
Breast Cancer Res Treat; 2011 Jul; 128(1):79-84. PubMed ID: 20676756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]